AAAAAA

   
Results: 1-25 | 26-26
Results: 1-25/26
TRANSFERABILITY TO CLINICAL-PRACTICE OF THE RESULTS OF CONTROLLED CLINICAL-TRIALS - THE CASE OF ANTIEMETIC PROPHYLACTIC TREATMENT FOR CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING
Authors: DELFAVERO A ROILA F DEANGELIS V TONATO M BALLATORI E TUMOLO S MENEGHETTI L NEGRI D DELLAGASPERA S PRESOT C MURAN G LUCENTI A CICCARESE G PALLADINO MA PORROZZI S SABBATINI R DEPENNI R FEDERICO M SILINGARDI V SANSONI E MALTONI M MILANDRI C AMADORI D SABBIONI R NORTILLI R CETTO GL DOGLIOTTI L BUNIVA T GORZEGNO G LOPEZ M AMODIO A CONTI F FOGGI CM GIGLIO A DESIO L MANENTE P BERNARDO G STRADA MR VILLANI G GALLO L MERLINI L CAROTI C MAZZOTTA S FORCIGNANO R QUARTA G PACILIO C IODICE G ROSATI G MALACARNE P DONATI D MACCAFERRI R COMELLA G CASARETTI R CARRECA I RAUSA L FOSSER V SCHIAVON S GIOFFRE FM VENUTI A AMUNNI G VILLANUCCI A CONTU A PAZZOLA A PALMIOTTI G GAROFOLO G EPIFANI C GIORDANO M ANTIMI M MINELLI M DEVITA F DIGRAZIA M CRUCIANI G MONTANARI L MARCHEI P AMICI S ALESSANDRONI P CECCOLINI M CATTANEO MT ORLANDINI B AGOSTARA B MARZI M DIONISI MS DICOSTANZO F TROCCOLI L
Citation: A. Delfavero et al., TRANSFERABILITY TO CLINICAL-PRACTICE OF THE RESULTS OF CONTROLLED CLINICAL-TRIALS - THE CASE OF ANTIEMETIC PROPHYLACTIC TREATMENT FOR CANCER CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, Annals of oncology, 9(7), 1998, pp. 759-765
MITOXANTRONE (M) AND TAXOL (T) AS FIRST LINE CHEMOTHERAPY IN PATIENTSWITH ADVANCED BREAST-CANCER (ABC)
Authors: DICOSTANZO F SDROBOLINI A MANZIONE L BILANCIA D DINOTA A ROCCA A GASPERONI S GIUSTINI L ACITO L COLOZZA MA GORI S MOSCONI AM CONTU A
Citation: F. Dicostanzo et al., MITOXANTRONE (M) AND TAXOL (T) AS FIRST LINE CHEMOTHERAPY IN PATIENTSWITH ADVANCED BREAST-CANCER (ABC), Annals of oncology, 9, 1998, pp. 111-111
ADJUVANT CHEMOTHERAPY WITH PELF IN OPERABLE GASTRIC-CANCER - (STAGE IB, II, IIIA-B AND IV T4N2MO)
Authors: DICOSTANZO F GASPERONI S CARLINI P TONATO M LABIANCA R BRAVI S FORNARINI G BISAGNI G SDROBOLINI A MANZIONE L
Citation: F. Dicostanzo et al., ADJUVANT CHEMOTHERAPY WITH PELF IN OPERABLE GASTRIC-CANCER - (STAGE IB, II, IIIA-B AND IV T4N2MO), Annals of oncology, 9, 1998, pp. 252-252
HOME THERAPY WITH CAPECITABINE IN COLORECTAL-CANCER PATIENTS
Authors: DICOSTANZO F SDROBOLINI A GASPERONI S
Citation: F. Dicostanzo et al., HOME THERAPY WITH CAPECITABINE IN COLORECTAL-CANCER PATIENTS, Annals of oncology, 9, 1998, pp. 22-22
ADJUVANT CHEMOTHERAPY IN COMPLETE RESECTED GASTRIC-CANCER - EVALUATION IN DOUBLE-LEFT-ARROW-60 VS GREATER-THAN-60 YEARS PTS
Authors: DICOSTANZO F GASPERONI S ROSSETTI R OLMEO N ZIRONI S GILLI G ROCCA A ROVEJ R LEONARDI F BRUNO L CATALANO G FOA P PARRINELLO GA CAVICCHI F ANTIMI M ANGIONA S
Citation: F. Dicostanzo et al., ADJUVANT CHEMOTHERAPY IN COMPLETE RESECTED GASTRIC-CANCER - EVALUATION IN DOUBLE-LEFT-ARROW-60 VS GREATER-THAN-60 YEARS PTS, Annals of oncology, 9, 1998, pp. 65-65
HIGH-DOSE FOLINIC ACID AND 5-FLUOROURACIL ALONE OR COMBINED WITH HYDROXYUREA IN ADVANCED COLORECTAL-CANCER - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH
Authors: DICOSTANZO F GASPERONI S MALACARNE P BELSANTI V LUPPI G MARZOLA M CORGNA E SDROBOLINI A PASSALACQUA R FIGOLI F ALGERI R ZIRONI S ANGIONA S BONI C
Citation: F. Dicostanzo et al., HIGH-DOSE FOLINIC ACID AND 5-FLUOROURACIL ALONE OR COMBINED WITH HYDROXYUREA IN ADVANCED COLORECTAL-CANCER - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH, American journal of clinical oncology, 21(4), 1998, pp. 369-375
PHASE-I-II TRIAL OF MITOXANTRONE(M) AND TAXOL(T) IN ADVANCED BREAST-CANCER
Authors: GUISTINI L DICOSTANZO F SDROBOLINI A BILANCIA D VALENTI L ANGIONA S GASPERONI S BARTOLUCCI R ACITO L MANZIONE L
Citation: L. Guistini et al., PHASE-I-II TRIAL OF MITOXANTRONE(M) AND TAXOL(T) IN ADVANCED BREAST-CANCER, Breast, 6(5), 1997, pp. 320-320
EFFECTIVENESS OF ANTIEMETIC DRUGS IN PREVENTION OF CHEMOTHERAPY (CT)-INDUCED ACUTE EMESIS
Authors: DEANGELIS V CICCARESE G ALESSANDRONI P CATTANEO MT AGOSTARA B ATZENI M DIONISI S DICOSTANZO F TROCCOLI G
Citation: V. Deangelis et al., EFFECTIVENESS OF ANTIEMETIC DRUGS IN PREVENTION OF CHEMOTHERAPY (CT)-INDUCED ACUTE EMESIS, European journal of cancer, 33, 1997, pp. 57-57
VINORELBINE IS WELL TOLERATED AND ACTIVE IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A 2-STAGE PHASE-II STUDY
Authors: GRIDELLI C PERRONE F GALLO C DEMARINIS F IANNIELLO G CIGOLARI S CARIELLO S DICOSTANZO F DAPRILE M ROSSI A MIGLIORINO R BARTOLUCCI R BIANCO AR PERGOLA M MONFARDINI S
Citation: C. Gridelli et al., VINORELBINE IS WELL TOLERATED AND ACTIVE IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED NONSMALL CELL LUNG-CANCER - A 2-STAGE PHASE-II STUDY, European journal of cancer, 33(3), 1997, pp. 392-397
DELAYED EMESIS INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - DO WE NEED TO TREAT ALL PATIENTS
Authors: BALLATORI E ROILA F DEANGELIS V RIVA E BARBIERI P DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S COGNETTI F FERRARESI V FABI A TONACHELLA R CIRULLI S SABBATINI R FEDERICO M TRASSOLDATI A SILINGARDI V DONATI D MAESTRI A MALACARNE P RICCI S ANTONUZZO A ALLEGRINI G CONTE PF SALVATI F NUNZIATI F ANTILLI A CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI A MERIGGI F CORTESI E RAMPONI S LOCATELLI MC SANTORO A ZUCCHINELLI P MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: E. Ballatori et al., DELAYED EMESIS INDUCED BY MODERATELY EMETOGENIC CHEMOTHERAPY - DO WE NEED TO TREAT ALL PATIENTS, Annals of oncology, 8(6), 1997, pp. 561-567
DOUBLE-BLIND, MULTICENTER, RANDOMIZED TRIAL TO COMPARE THE EFFECT OF 2 DOSES OF ADRENOCORTICOTROPIC HORMONE VERSUS PLACEBO IN CONTROLLING DELAYED EMESIS AFTER HIGH-DOSE CISPLATIN IN ADULT PATIENTS WITH CANCER
Authors: PASSALACQUA R COCCONI G CAMINITI C SILINGARDI V BELLA MA BICHISAO E MICHIARA M MALAVASI V DONATI D DICOSTANZO F ROCCA A DISARRA S SCAGLIONE F FRASCHINI F
Citation: R. Passalacqua et al., DOUBLE-BLIND, MULTICENTER, RANDOMIZED TRIAL TO COMPARE THE EFFECT OF 2 DOSES OF ADRENOCORTICOTROPIC HORMONE VERSUS PLACEBO IN CONTROLLING DELAYED EMESIS AFTER HIGH-DOSE CISPLATIN IN ADULT PATIENTS WITH CANCER, Journal of clinical oncology, 15(6), 1997, pp. 2467-2473
HODGKINS-DISEASE PRESENTING BELOW THE DIAPHRAGM - THE EXPERIENCE OF THE GRUPPO-ITALIANO-STUDIO-LINFOMI (GISL)
Authors: IANNITTO E ACCURSO V FEDERICO M VALLISA D PIERESCA C GRAVINA SF DICOSTANZO F DITRAPANI R SILINGARDI V MARIANI G
Citation: E. Iannitto et al., HODGKINS-DISEASE PRESENTING BELOW THE DIAPHRAGM - THE EXPERIENCE OF THE GRUPPO-ITALIANO-STUDIO-LINFOMI (GISL), Haematologica, 82(6), 1997, pp. 676-682
FACTORS THAT PREDICT RESPONSE AND DISEASE-FREE SURVIVAL IN CLINICALLYADVANCED FOLLICULAR LYMPHOMAS
Authors: GENUA A BISCOTTINI B CINIERI S TROTTINI M DERENZO A ROTOLI B TAFUTO S ABATE G MILANI S MUSTACCHI G AMBROSI L LEONI P MASTRIA A LORUSSO V VECCHI A SACCHI S PALMIERI F VOLPE E AZZOLINI C DAMMACCO F DICOSTANZO F CAPARROTTI G GRIGNANI F DEANGELIS V ALSHARJABY N LIBERATI AM
Citation: A. Genua et al., FACTORS THAT PREDICT RESPONSE AND DISEASE-FREE SURVIVAL IN CLINICALLYADVANCED FOLLICULAR LYMPHOMAS, Blood, 90(10), 1997, pp. 842-842
HYDROXYUREA MAY INCREASE THE ACTIVITY OF FLUOROURACIL PLUS FOLINIC ACID IN ADVANCED GASTROINTESTINAL CANCER - PHASE-II STUDY
Authors: DICOSTANZO F ELTAANI H PARRIANI D TAGLIAVENTI M BARTOLUCCI R VALENTI L MANZIONE L MADEJEWICZ S
Citation: F. Dicostanzo et al., HYDROXYUREA MAY INCREASE THE ACTIVITY OF FLUOROURACIL PLUS FOLINIC ACID IN ADVANCED GASTROINTESTINAL CANCER - PHASE-II STUDY, Cancer investigation, 14(3), 1996, pp. 234-238
HIGH-DOSE FOLINIC ACID AND FLUOROURACIL WITH OR WITHOUT IFOSFAMIDE ISAN INACTIVE COMBINATION IN ADVANCED PANCREATIC-CANCER - A RANDOMIZED PHASE-II STUDY OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC)
Authors: DICOSTANZO F TAGLIAVENTI M CARLINI P ZIRONI S MAZZOCCHI B BELLA M DONATI D ACITO L MAGGIAN P ANGIONA S
Citation: F. Dicostanzo et al., HIGH-DOSE FOLINIC ACID AND FLUOROURACIL WITH OR WITHOUT IFOSFAMIDE ISAN INACTIVE COMBINATION IN ADVANCED PANCREATIC-CANCER - A RANDOMIZED PHASE-II STUDY OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC), American journal of clinical oncology, 19(3), 1996, pp. 307-310
THE COMBINATION OF CISPLATIN, DOXORUBICIN, AND MITOMYCIN (PAM) COMPARED WITH THE FAM REGIMEN IN TREATING ADVANCED GASTRIC-CARCINOMA - A PHASE-II RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH
Authors: DELISI V COCCONI G ANGELINI F CAVICCHI F DICOSTANZO F GILLI G RODINO C SOLDANI M TONATO M FINARDI C
Citation: V. Delisi et al., THE COMBINATION OF CISPLATIN, DOXORUBICIN, AND MITOMYCIN (PAM) COMPARED WITH THE FAM REGIMEN IN TREATING ADVANCED GASTRIC-CARCINOMA - A PHASE-II RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH, Cancer, 77(2), 1996, pp. 245-250
TOLERABILITY OF HIGH-DOSE CYCLOPHOSPHAMIDE AND CARBOPLATINUM FOLLOWEDBY CM-CSF INFUSION
Authors: CINIERI S DICLEMENTE F MANCINI S FERRAJOLI A GENUA A ADAMO S DICOSTANZO F BUZZI F BISCOTTINI B LIBERATI AM
Citation: S. Cinieri et al., TOLERABILITY OF HIGH-DOSE CYCLOPHOSPHAMIDE AND CARBOPLATINUM FOLLOWEDBY CM-CSF INFUSION, European journal of cancer, 31A, 1995, pp. 253-253
HYDROXYUREA (HU), HIGH-DOSE FOLINIC ACID (L-FA) AND 5FU VS HU, 5FU AND INTERFERON-ALFA-2B (IFN) IN ADVANCED COLORECTAL-CANCER (ACRC) - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC)
Authors: DICOSTANZO F SDROBOLINI A MARZOLA S ZIRONI S CONTU A PUCCI E RODINO C CORGNA E ALGERI R BISAGNI G ANGIONA S
Citation: F. Dicostanzo et al., HYDROXYUREA (HU), HIGH-DOSE FOLINIC ACID (L-FA) AND 5FU VS HU, 5FU AND INTERFERON-ALFA-2B (IFN) IN ADVANCED COLORECTAL-CANCER (ACRC) - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC), European journal of cancer, 31A, 1995, pp. 721-721
CHEMOTHERAPY OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A COMPARISON OF3 ACTIVE REGIMENS - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC)
Authors: CRINO L CLERICI M FIGOLI F CARLINI P CECI G CORTESI E CARPI A SANTINI A DICOSTANZO F BONI C MEACCI M CORGNA E DARWISH S SCARCELLA L SANTUCCI A BALLATORI E
Citation: L. Crino et al., CHEMOTHERAPY OF ADVANCED NON-SMALL-CELL LUNG-CANCER - A COMPARISON OF3 ACTIVE REGIMENS - A RANDOMIZED TRIAL OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH (GOIRC), Annals of oncology, 6(4), 1995, pp. 347-353
PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY
Authors: BALLATORI E ROILA F DEANGELIS V TONATO M RIVA E BARBIERI P DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S COGNETTI F FERRARESI V FABI A COLELLA E CIRULLI S SABBATINI R FEDERICO M BARBIERI F SILINGARDI V ANNA S DONATI D MAESTRI A MALACARNE P RICCI S ANTONUZZO A CONTE PF SALVATI F NUNZIATI F ANTILLI A CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI Z MERIGGI F CORTESI E CALABRO F CARLO S LUPORINI G DANTONA A SANTORO A GIACOBONE A MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: E. Ballatori et al., PERSISTENCE OF EFFICACY OF 3 ANTIEMETIC REGIMENS AND PROGNOSTIC FACTORS IN PATIENTS UNDERGOING MODERATELY EMETOGENIC CHEMOTHERAPY, Journal of clinical oncology, 13(9), 1995, pp. 2417-2426
SUPERIORITY OF 3-DRUG COMBINATION CHEMOTHERAPY VERSUS CISPLATIN-ETOPOSIDE IN ADVANCED NONSMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL BY THEITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH
Authors: CRINO L CLERICI M FIGOLI F BARDUAGNI M CARLINI P CECI G CORTESI E CARPI A SANTINI A DICOSTANZO F BONI C MEACCI M CORGNA E SANTUCCI A BALLATORI E TONATO M
Citation: L. Crino et al., SUPERIORITY OF 3-DRUG COMBINATION CHEMOTHERAPY VERSUS CISPLATIN-ETOPOSIDE IN ADVANCED NONSMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL BY THEITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCH, Lung cancer, 12, 1995, pp. 125-132
DEXAMETHASONE, GRANISETRON, OR BOTH FOR THE PREVENTION OF NAUSEA AND VOMITING DURING CHEMOTHERAPY FOR CANCER
Authors: ROILA F BALLATORI E DEANGELIS V TONATO M RIVA E PANZA MT DELFAVERO A BASURTO C CICCARESE G PALLADINO MA MOSCONI AM ANASTASI P PICCIAFUOCO M CAMPORA E CHIARA S ROSSO R COGNETTI F FERRARESI V FABI A TONACHELLA R CIRULLI S SABBATINI R FEDERICO M DEPENNI R SILINGARDI V DONATI D MAESTRI A MALACARNE P RICCI S MUTTINI MP CONTE PF SALVATI F NUNZIATI F SIGNORA M CATALANO G CASCINU S DICOSTANZO F TAGLIAVENTI M ZANIBONI A MERIGGI F CORTESI E TRINCA C LUPORINI G LOCATELLI MC SANTORO A ZUCCHINELLI P MANTELLINI E FERRETTI G BONI C MORETTI G SCAGLIOTTI G DANIELE O LISSONI A TATEO S
Citation: F. Roila et al., DEXAMETHASONE, GRANISETRON, OR BOTH FOR THE PREVENTION OF NAUSEA AND VOMITING DURING CHEMOTHERAPY FOR CANCER, The New England journal of medicine, 332(1), 1995, pp. 1-5
PHASE-II TRIAL OF 5-FLUOROURACIL AND THE NATURAL 1-ISOMER OF FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL-CARCINOMA
Authors: ROSSO R MAZZEI T SOBRERO A MINI E CARTEI G CONTE P LABIANCA R CARTEI F FALCONE A PANCERA G BARSANTI G DICOSTANZO F GUGLIELMI A BOLLI E TIXI L ASCHELE C RIBECCO A PERITI P
Citation: R. Rosso et al., PHASE-II TRIAL OF 5-FLUOROURACIL AND THE NATURAL 1-ISOMER OF FOLINIC ACID IN THE TREATMENT OF ADVANCED COLORECTAL-CARCINOMA, European journal of cancer, 30A(3), 1994, pp. 338-343
FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN COMBINATION VERSUS PELF CHEMOTHERAPY IN ADVANCED GASTRIC-CANCER - A PROSPECTIVE RANDOMIZED TRIAL OF THE ITALIAN-ONCOLOGY-GROUP-FOR-CLINICAL-RESEARCH
Authors: COCCONI G BELLA M ZIRONI S ALGERI R DICOSTANZO F DELISI V LUPPI G MAZZOCCHI B RODINO C SOLDANI M GILLI G FINARDI C
Citation: G. Cocconi et al., FLUOROURACIL, DOXORUBICIN, AND MITOMYCIN COMBINATION VERSUS PELF CHEMOTHERAPY IN ADVANCED GASTRIC-CANCER - A PROSPECTIVE RANDOMIZED TRIAL OF THE ITALIAN-ONCOLOGY-GROUP-FOR-CLINICAL-RESEARCH, Journal of clinical oncology, 12(12), 1994, pp. 2687-2693
INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL
Authors: DELTURCO MR PALLI D CARIDDI A CIATTO S PACINI P DISTANTE V AZZINI V BELSANTI V BARTOLUCCI R DICOSTANZO F BERTUSI M DANESE S GIARDINA G DAIUTO G UCCELLO V DELEO G PUNZO C GOSSO P GRISO C LOCATELLI E MANSUTTI M SANDRI P MOLINO AM SCHINCAGLIA P TIENGHI A
Citation: Mr. Delturco et al., INTENSIVE DIAGNOSTIC FOLLOW-UP AFTER TREATMENT OF PRIMARY BREAST-CANCER - A RANDOMIZED TRIAL, JAMA, the journal of the American Medical Association, 271(20), 1994, pp. 1593-1597
Risultati: 1-25 | 26-26